Status:
TERMINATED
Managing Pain in Patients With Plantar Fasciitis - A Blinded Randomized Controlled Trial
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Plantar Fasciitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Plantar fasciitis (PF), a leading cause of persistent heel pain, results in almost a million physician visits annually. Conservative treatment is often the first line of management with insoles being ...
Detailed Description
Carbon fiber insoles (VKTRY, Milford, CT, USA) were initially designed to increase ground forces leading to a harder push off for faster running or higher jumping. To enable energy return, the insoles...
Eligibility Criteria
Inclusion
- Adult patients (over 18 years old) with plantar fasciitis
- Adults who are competent and able to consent on their own behalf
- Patients who are seen at MGH Boston, MGH Waltham and Newton Wellesley Hospital
Exclusion
- Patients who received an injection in the last 6 months in their plantar fascia
- Patients who will need to be treated surgically
- Patients who are non-English speaking
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06116799
Start Date
April 1 2022
End Date
May 6 2023
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114